E-Book | March 21, 2024

First-In-Human Solution For Small And Large Molecules

Source: Altasciences
GettyImages-517118579 patient

With clinical pharmacology units in the U.S. and Canada, we offer you two regulatory pathways (IND or CTA). The clinics’ flexible formats can be configured to the specific requirements of your program. This includes specialized areas for intense monitoring and procedures, secure facilities with Schedule I licensing, and in-house pharmacies with compounding and full investigational product (IP) drug preparation capabilities. Comfortable, efficient, and well-equipped for long or short stays, our clinics are staffed by experts working with a fully integrated eDC system to ensure participant safety, and the accurate, timely collection of your data.

access the E-Book!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader